Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum beta-lactamase–producing Klebsiella pneumoniae and Escherichia coli
Diagnostic Microbiology and Infectious Disease, 08/22/2011

1 Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia Clinical Microbiology and Infection, April 17, 2012    Clinical Article

2 Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B Alimentary Pharmacology and Therapeutics, April 4, 2012    Clinical Article

3 Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial The Lancet Infectious Diseases, March 27, 2012    Clinical Article

4 Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials Clinical Microbiology and Infection, April 18, 2012    Clinical Article

5 Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia Clinical Microbiology and Infection, April 25, 2012    Clinical Article

6 Statin use and the risk of Clostridium difficile in academic medical centres Gut, April 11, 2012    Clinical Article

7 The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States The Journal of Infectious Diseases, April 2, 2012

8 Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study Clinical Microbiology and Infection, April 19, 2012    Clinical Article

9 Use of interferon-gamma release assays in a health care worker screening program: Experience From a tertiary care centre in the United States Canadian Respiratory Journal, April 24, 2012    Clinical Article

10 Macrolides vs. quinolones for community-acquired pneumonia: Meta-analysis of randomized controlled trials Clinical Microbiology and Infection, March 26, 2012    Evidence Based Medicine    Clinical Article

11 Antibiotic treatment of children with community-acquired pneumonia: Comparison of penicillin or ampicillin versus cefuroxime Pediatric Pulmonology, April 9, 2012    Clinical Article

12 Adjunct immunotherapies for tuberculosis The Journal of Infectious Diseases, April 3, 2012

13 A multicentre, open-label, randomised comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalised subjects with complicated intra-abdominal infections Clinical Microbiology and Infection, April 17, 2012

14 The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline HIV Medicine, April 17, 2012    Clinical Article

15 A Randomized Controlled Trial of Zinc as Adjuvant Therapy for Severe Pneumonia in Young Children Pediatrics, April 13, 2012

16 Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009 JAMA, April 11, 2012

17 Diagnostics for community-acquired and atypical pneumonia Current Opinion in Pulmonary Medicine, April 6, 2012

18 Illness severity in community-onset invasive Staphylococcus aureus infection and the presence of virulence genes The Journal of Infectious Diseases, April 10, 2012

19 Are Prosthetic Spacers Safe to Use in 2-Stage Treatment for Infected Total Knee Arthroplasty Journal of Arthroplasty, April 18, 2012

20 Transmission of Staphylococcus aureus From Mothers to Newborns The Pediatric Infectious Disease Journal, April 12, 2012